SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

        Date of Report (Date of earliest event reported): AUGUST 19, 2002



                               GLYCOGENESYS, INC.
                               ------------------
               (Exact name of registrant as specified in charter)



           NEVADA                          0-26476                33-0231238
           ------                          -------                ----------
(State or Other Jurisdiction             (Commission            (IRS Employer
     of Incorporation)                   File Number)        Identification No.)


                31 ST. JAMES AVENUE, BOSTON, MASSACHUSETTS 02116
                ------------------------------------------------
              (Address of principal executive officers) (Zip Code)

       Registrant's telephone number, including area code: (617) 422-0674
                                                           --------------

                                 NOT APPLICABLE
                                 --------------
          (Former name or former address, if changed since last report)






ITEM 9.  REGULATION FD DISCLOSURE

         GlycoGenesys, Inc. (the "Company") is furnishing under Item 9 of this
Current Report on Form 8-K the information included as Exhibit 99.1 to this
report. Exhibit 99.1 contains the certification of the Company's Chief Executive
Officer and Chief Financial Officer pursuant to 18 U.S. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 which was transmitted
to the Securities and Exchange Commission in correspondence accompanying the
Company Quarterly Report of Form 10-Q for the quarter ending June 30, 2002.

         This Report of Form 8-K will not be deemed an admission as to the
materiality of any information in the report that is required to be disclosed
solely by Regulation FD.


ITEM 7.  FINANCIAL STATEMENTS AND EXHIBITS

The following exhibits are filed as part of this Form 8-K.

Exhibit Number    Description
--------------    -----------

99.1              CEO and CFO Certification pursuant to Section 906 of
                  Sarbanes-Oxley Act of 2002.








                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


Dated:  August 19, 2002                By: /s/ Bradley J. Carver
                                           -------------------------------------
                                           Bradley J. Carver
                                           President and Chief Executive Officer